These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 35638041)

  • 21. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of Neuromuscular Blocking Agents in Acute Respiratory Distress Syndrome: An Updated Meta-Analysis of Randomized Controlled Trials.
    Wei XB; Wang ZH; Liao XL; Guo WX; Qin TH; Wang SH
    Front Pharmacol; 2019; 10():1637. PubMed ID: 32063852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological characteristics, practice of ventilation, and clinical outcome in patients at risk of acute respiratory distress syndrome in intensive care units from 16 countries (PRoVENT): an international, multicentre, prospective study.
    Neto AS; Barbas CSV; Simonis FD; Artigas-Raventós A; Canet J; Determann RM; Anstey J; Hedenstierna G; Hemmes SNT; Hermans G; Hiesmayr M; Hollmann MW; Jaber S; Martin-Loeches I; Mills GH; Pearse RM; Putensen C; Schmid W; Severgnini P; Smith R; Treschan TA; Tschernko EM; Melo MFV; Wrigge H; de Abreu MG; Pelosi P; Schultz MJ; ;
    Lancet Respir Med; 2016 Nov; 4(11):882-893. PubMed ID: 27717861
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuromuscular blocking agents in acute respiratory distress syndrome: a systematic review and meta-analysis of randomized controlled trials.
    Alhazzani W; Alshahrani M; Jaeschke R; Forel JM; Papazian L; Sevransky J; Meade MO
    Crit Care; 2013 Mar; 17(2):R43. PubMed ID: 23497608
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of Cisatracurium Versus Atracurium in Early ARDS.
    Moore L; Kramer CJ; Delcoix-Lopes S; Modrykamien AM
    Respir Care; 2017 Jul; 62(7):947-952. PubMed ID: 28351905
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The pharmacokinetics of cisatracurium in patients with acute respiratory distress syndrome.
    Dhonneur G; Cerf C; Lagneau F; Mantz J; Gillotin C; Duvaldestin P
    Anesth Analg; 2001 Aug; 93(2):400-4 , 3rd contents page. PubMed ID: 11473869
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Early application of airway pressure release ventilation may reduce the duration of mechanical ventilation in acute respiratory distress syndrome.
    Zhou Y; Jin X; Lv Y; Wang P; Yang Y; Liang G; Wang B; Kang Y
    Intensive Care Med; 2017 Nov; 43(11):1648-1659. PubMed ID: 28936695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Timing of low tidal volume ventilation and intensive care unit mortality in acute respiratory distress syndrome. A prospective cohort study.
    Needham DM; Yang T; Dinglas VD; Mendez-Tellez PA; Shanholtz C; Sevransky JE; Brower RG; Pronovost PJ; Colantuoni E
    Am J Respir Crit Care Med; 2015 Jan; 191(2):177-85. PubMed ID: 25478681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enteral Nutrition Safety and Outcomes of Patients with COVID-19 on Continuous Infusion of Neuromuscular Blockers: A Retrospective Study.
    Al-Dorzi HM; Yaqoub R; Alalmaee R; Almutairi G; Almousa A; Aldawsari L
    J Nutr Metab; 2023; 2023():8566204. PubMed ID: 37415869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical study of early use of neuromuscular blocking agents in patients with severe sepsis and acute respiratory distress syndrome].
    Lyu G; Wang X; Jiang W; Cai T; Zhang Y
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):325-9. PubMed ID: 24809261
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Resistance to rocuronium and cisatracurium in a patient with a spinal injury and acute respiratory distress syndrome.
    Riley K; Yampolsky N; Hakma Z; Moussouttas M
    Am J Health Syst Pharm; 2015 Apr; 72(8):632-5. PubMed ID: 25825186
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Paralysis for the Management of ARDS.
    Grawe ES; Bennett S; Hurford WE
    Respir Care; 2016 Jun; 61(6):830-8. PubMed ID: 27094392
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral phrenic nerve block as an effective means of controlling inspiratory efforts in a COVID-19 patient.
    Nakayama R; Iwamoto Y; Bunya N; Sawada A; Takahashi K; Goto Y; Kasai T; Kakizaki R; Uemura S; Narimatsu E
    Respir Med Case Rep; 2021; 33():101455. PubMed ID: 34189030
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of Sedatives and Neuromuscular-Blocking Agents in Mechanically Ventilated Patients with COVID-19 ARDS.
    Ego A; Peluso L; Gorham J; Diosdado A; Restuccia G; Creteur J; Taccone FS
    Microorganisms; 2021 Nov; 9(11):. PubMed ID: 34835518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Validation of neuromuscular blocking agent use in acute respiratory distress syndrome: a meta-analysis of randomized trials.
    Chang W; Sun Q; Peng F; Xie J; Qiu H; Yang Y
    Crit Care; 2020 Feb; 24(1):54. PubMed ID: 32066488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Driving pressure-guided ventilation decreases the mechanical power compared to predicted body weight-guided ventilation in the Acute Respiratory Distress Syndrome.
    Haudebourg AF; Tuffet S; Perier F; Razazi K; de Prost N; Mekontso Dessap A; Carteaux G
    Crit Care; 2022 Jun; 26(1):185. PubMed ID: 35725498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Limiting sedation for patients with acute respiratory distress syndrome - time to wake up.
    Shah FA; Girard TD; Yende S
    Curr Opin Crit Care; 2017 Feb; 23(1):45-51. PubMed ID: 27898439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.